1-2 of 2
Habiba Attalah
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Bemcentinib in Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Failing Hypomethylating Agents

Anne Sophie Kubasch, Pierre Peterlin, MD, Thomas Cluzeau, MD PhD, Katharina S. Götze, Katja Sockel, MD, Raphael Teipel, MD, Madlen Jentzsch, MD, Sabine Kayser, MD, Habiba Attalah, Fatiha Chermat, Silke Gloaguen, Msc, Katja Jersemann, Dorothea Schipp, Aristoteles Giagounidis, Stuart McPherson, BSc, Irene Tirado-González, Arjan van de Loosdrecht, MD PhD, Pierre Fenaux, MD PhD, Uwe Platzbecker, Hind Medyouf, Lionel Ades, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-140240
Published: 2020
Journal Articles

APR-246 Combined with Azacitidine (AZA) in TP53 Mutated Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). a Phase 2 Study By the Groupe Francophone Des Myélodysplasies (GFM)

Thomas Cluzeau, MD PhD, Marie Sebert, MD, Ramy Rahmé, MD, Stefania Cuzzubbo, Anouk Walter-petrich, Jacqueline Lehmann che, Pierre Peterlin, Blandine Beve, Habiba Attalah, Fatiha Chermat, Elsa Miekoutima, Odile Beyne-Rauzy, Christian Recher, MD PhD, Aspasia Stamatoullas, MD, Lise Willems, MD, Emmanuel Raffoux, MD, Céline Berthon, MD PhD, Bruno Quesnel, Antoine Carpentier, David A Sallman, MD, Sylvie Chevret, MD PhD, Lionel Ades, MD PhD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 677.
https://doi.org/10.1182/blood-2019-125579
Published: 2019